These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4299465)

  • 41. Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).
    Klings ES; Hill NS; Ieong MH; Simms RW; Korn JH; Farber HW
    Arthritis Rheum; 1999 Dec; 42(12):2638-45. PubMed ID: 10616012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma).
    Hietaharju A; Jääskeläinen S; Kalimo H; Hietarinta M
    Muscle Nerve; 1993 Nov; 16(11):1204-12. PubMed ID: 8413372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Probenecid in treatment of scleroderma. Case report].
    Filipowicz-Sosnowska A; Sadowska-Wróblewska M
    Reumatologia; 1974; 12(1):77-81. PubMed ID: 4841440
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of scleroderma in newborn with vitamin E].
    WENIG H; WESTPHAL J
    Zentralbl Gynakol; 1958 Oct; 80(43):1673-7. PubMed ID: 13626040
    [No Abstract]   [Full Text] [Related]  

  • 45. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J; Helin P; Rasmussen O; Lorenzen I
    Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical experience with anabolic steroids and nitrogen balance in scleroderma].
    Uragami Y
    Acta Dermatol Kyoto Engl Ed; 1967 Nov; 62(4):277-81. PubMed ID: 5632134
    [No Abstract]   [Full Text] [Related]  

  • 47. Salazopyrin (azulfidine) treatment in scleroderma.
    Dover N
    Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diucifon in the therapy of dermatoses].
    Grebeniuk VN; Fedorova EG; Sheklakova MN
    Vestn Dermatol Venerol; 1980 Feb; (2):41-3. PubMed ID: 6986724
    [No Abstract]   [Full Text] [Related]  

  • 49. [Osseous, muscular and articular lesions in scleroderma].
    Stoichita S; Safiresco T; Boicesco L; Brosteanu E; Steclaci A; Debau M; Marinesco E; Gavrila I; Gavrila D
    Przegl Dermatol; 1965; 52(3):243-9. PubMed ID: 5830798
    [No Abstract]   [Full Text] [Related]  

  • 50. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Renal involvement in scleroderma].
    Boffa JJ; Rossert J
    Rev Prat; 2002 Nov; 52(17):1910-4. PubMed ID: 12532868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of myopathies].
    Esslen E
    Bibl Psychiatr Neurol; 1969; 139():480-93. PubMed ID: 5406917
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study.
    Levy Y; Amital H; Langevitz P; Nacci F; Righi A; Conforti L; Generini S; Matucci Cerinic M; Shoenfeld Y
    Arthritis Rheum; 2004 Mar; 50(3):1005-7. PubMed ID: 15022346
    [No Abstract]   [Full Text] [Related]  

  • 54. Response of patients with renal involvement by progressive systemic sclerosis to antihypertensive therapy.
    Traub YM; Shapiro AP; Osial TA; Rodnan GP; Medsger TA; Leb DE; Christy WC
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():395s-398s. PubMed ID: 7318343
    [No Abstract]   [Full Text] [Related]  

  • 55. [Scleroderma and its visceral complications].
    Huriez C
    Maroc Med; 1972 Jun; 52(558):331-44. PubMed ID: 4636029
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease.
    Rossi B; Siciliano G; Risaliti R; Muratorio A
    Ital J Neurol Sci; 1990 Feb; 11(1):37-42. PubMed ID: 2332324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Muscular performance and vitamin E in cystic fibrosis.
    Levin S
    Arch Dis Child; 1974 Mar; 49(3):247. PubMed ID: 4596666
    [No Abstract]   [Full Text] [Related]  

  • 58. [A CASE OF GENERALIZED SCLERODERMA WITH PULMONARY AND OTHER INTERNAL CHANGES].
    SMAGA M; SMAJKIEWICZ L; SAWA J
    Gruzlica (1926); 1964 Jan; 32():55-9. PubMed ID: 14127500
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute prednisone-induced disabling myalgias in scleroderma.
    Thompson MD; Jim LK; Bentz RR; Alexander DK
    Arthritis Rheum; 1981 Apr; 24(4):639-40. PubMed ID: 7213447
    [No Abstract]   [Full Text] [Related]  

  • 60. Vitamin E as a useful therapeutic agent.
    Ayres S; Mihan R
    J Am Acad Dermatol; 1983 Jan; 8(1):133-4. PubMed ID: 6826800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.